Mitsui Chemicals Inc
No enriched coverage for $MITUF in the last 7 days.
No SEC Form 4 filings for $MITUF in the last 30 days.
See all $MITUF insider activity →Mitsui Chemicals, Inc. introduced InnoCell P-Type, a cell culture plate designed for 3D organoid models and drug discovery, with high oxygen permeability and low autofluorescence. The product aims to enhance drug screening processes. According to the company, it is an early-stage launch in the life sciences tooling sector.
Mitsui Chemicals said it completed its acquisition of U.S. oral care company Ultradent Products on Aug. 14, 2026, earlier than the expected September timeline, after competition and foreign investment approvals were obtained. It plans to move its oral care global HQ function from Japan to a U.S. holding company and will review the deal’s impact on consolidated financial results.
Ultradent Products agreed to be acquired by Mitsui Chemicals in a $900 million deal, with closing expected in September 2026, subject to regulatory approvals and filings. Mitsui Chemicals registered MC Dental Holdings America in Utah to oversee its global oral-care business, with headquarters in South Jordan. Ultradent reported 2025 sales of $372.1 million and net income of $24.0 million.
Recent MITUF coverage spans mergers & acquisitions, financial news and technology.
Mitsui Chemicals, Inc. introduced InnoCell P-Type, a cell culture plate designed for 3D organoid models and drug discovery, with high oxygen permeability and low autofluorescence. The product aims to enhance drug screening processes. According to the company, it is an early-stage launch in the life sciences tooling sector.
Mitsui Chemicals said it completed its acquisition of U.S. oral care company Ultradent Products on Aug. 14, 2026, earlier than the expected September timeline, after competition and foreign investment approvals were obtained. It plans to move its oral care global HQ function from Japan to a U.S. holding company and will review the deal’s impact on consolidated financial results.
Ultradent Products agreed to be acquired by Mitsui Chemicals in a $900 million deal, with closing expected in September 2026, subject to regulatory approvals and filings. Mitsui Chemicals registered MC Dental Holdings America in Utah to oversee its global oral-care business, with headquarters in South Jordan. Ultradent reported 2025 sales of $372.1 million and net income of $24.0 million.
Mitsui Chemicals said it joined CuspAI’s AI Materials Foundry as a founding member, joining a 45+ member network that includes Nvidia, Meta, Samsung, Henkel, Applied Materials, Tokyo Electron and others. The network uses CuspAI’s MIRA platform to combine data, computing resources and facilities to speed AI-driven materials discovery. Mitsui aims to strengthen R&D and explore new business opportunities.
AlphAI scores every news story that mentions MITUF with an AI model for sentiment and relevance, and aggregates insider trades from Mitsui Chemicals Inc's SEC EDGAR Form 4 filings. Figures refresh continuously.
Mitsui Chemicals, Inc. introduced InnoCell P-Type, a cell culture plate designed for 3D organoid models and drug discovery, with high oxygen permeability and low autofluorescence. The product aims to enhance drug screening processes. According to the company, it is an early-stage launch in the life sciences tooling sector.
1 min readMitsui Chemicals said it completed its acquisition of U.S. oral care company Ultradent Products on Aug. 14, 2026, earlier than the expected September timeline, after competition and foreign investment approvals were obtained. It plans to move its oral care global HQ function from Japan to a U.S. holding company and will review the deal’s impact on consolidated financial results.
2 min readUltradent Products agreed to be acquired by Mitsui Chemicals in a $900 million deal, with closing expected in September 2026, subject to regulatory approvals and filings. Mitsui Chemicals registered MC Dental Holdings America in Utah to oversee its global oral-care business, with headquarters in South Jordan. Ultradent reported 2025 sales of $372.1 million and net income of $24.0 million.
6 min readMitsui Chemicals said it joined CuspAI’s AI Materials Foundry as a founding member, joining a 45+ member network that includes Nvidia, Meta, Samsung, Henkel, Applied Materials, Tokyo Electron and others. The network uses CuspAI’s MIRA platform to combine data, computing resources and facilities to speed AI-driven materials discovery. Mitsui aims to strengthen R&D and explore new business opportunities.
3 min read
